Neurocrine Biosciences (NBIX) Earnings (2010 - 2026)
Neurocrine Biosciences (NBIX) earnings from Jun 30, 2010 to Mar 31, 2026. The TTM Neurocrine Biosciences (NBIX) earnings is $669M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Neurocrine Biosciences (NBIX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +118.64% |
| 3 Years TTM | +118.61% |
| 5 Years TTM | +10.71% |
| All Time TTM | +34.77% |
Annual Earnings change of Neurocrine Biosciences (NBIX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $198M | -58.65% |
| 2025 | $479M | +40.23% |
| 2024 | $341M | +36.68% |
| 2023 | $250M | +61.62% |
| 2022 | $155M | +72.43% |
| 2021 | $90M | -78.00% |
| 2020 | $407M | +1000.81% |
| 2019 | $37M | +75.36% |
| 2018 | $21M | -114.80% |
| 2017 | -$143M | +1.03% |
| 2016 | -$141M | +58.65% |
| 2015 | -$89M | +46.89% |
| 2014 | -$61M | +31.35% |
| 2013 | -$46M | -1016.30% |
| 2012 | $5.03M | -86.61% |
| 2011 | $38M | -571.39% |
| 2010 | -$7.97M | -84.38% |
| 2009 | -$51M | N/A |
Comparison Neurocrine Biosciences (NBIX) five years earnings CAGR with competitors
Neurocrine Biosciences (NBIX) five years earnings CAGR is 10.71%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +830.81% |
| INCR | INC Research Holdings Inc | 64.08% | +498.35% |
| TLRY | Tilray Brands Inc | 57.78% | +439.44% |
| PRGO | Perrigo Company plc | 51.08% | +376.95% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | +222.71% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +164.99% |
| UTHR | United Therapeutics Corp | 26.00% | +142.74% |
| SBFM | Sunshine Biopharma Inc | 23.97% | +123.78% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | +102.24% |
| AYTU | Aytu BioPharma Inc | 21.24% | +98.35% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | +61.42% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | +58.09% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | +10.43% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -2.56% |
| ZTS | Zoetis Inc - Class A | 8.54% | -20.29% |
| KMDA | Kamada Ltd | 6.87% | -35.85% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -53.07% |
| PRFX | PRF Technologies Ltd | 4.38% | -59.10% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -64.98% |
| CPHI | China Pharma Holdings Inc | 3.58% | -66.56% |
| BHC | Bausch Health Companies Inc | 3.48% | -67.49% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -72.61% |